New device could help sleep apnoea patients ditch CPAP masks
NCT ID NCT07343362
First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 4 times
Summary
This UK trial tests a device that uses mild electrical pulses to keep the airway open during sleep in people with obstructive sleep apnoea. It is for adults who cannot use standard CPAP therapy. The study will compare the device to usual CPAP care over three months to see if it improves breathing and sleep quality.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcutaneous electrical stimulation device (ZeusOSA)
- What this could lead to
- If it works, this could offer a new treatment option for people with sleep apnoea who struggle with CPAP machines.
- What could go wrong
- This is an early-stage trial with only 186 participants, so results may not apply to everyone. The device may not be as effective as CPAP or could cause discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 186 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adult participants (≥18 years) who have OSA with an AHI between 5-40 events/hour, as measured by the baseline sleep study (3 nights off CPAP). 2. If the participant fails to use CPAP sufficiently, defined as use of CPAP for less than 4 hours/night on fewer than 70% of nights over a minimum period of 3 months prior to enrolment. 3. Adults with a body mass index (BMI) of 18.5-32.0 kg/m2 (inclusive) 4. Adults without significant anatomical obstruction in the upper airway (e.g., normal sized tonsils). 5. Able and willing to provide informed written consent. 6. Access to a smartphone and internet at home. Exclusion Criteria: 1. Hypercapnic patients (pCO2\>6.0 kPa) or those with other features of obesity hypoventilation syndrome (elevated bicarbonate, HCO3- \>28mmol/L). 2. Adults with significantly enlarged tonsils (size 3-4) 3. Adults with polyps or adenoids, hypoglossal nerve palsy, 4. Adults with notable medical co-morbidities that could potentially impact participation in or the achievement of the study's objectives (e.g., significant heart failure (New York Heart Association, NYHA class III-IV), recent myocardial infarction (within 3 months) and significant cardiac arrhythmias, uncontrolled hypertension). 5. Participants with an active psychiatric condition that, in the opinion of the Investigator, may affect the participant's capacity to provide informed consent, adhere to study procedures, actively participate in the study, or compromise the integrity of study data. 6. Participants with active implantable medical devices, including but not limited to cardiac pacemakers, implantable cardioverter defibrillators (ICDs), cochlear implants, deep brain stimulation (DBS) systems, vagus nerve stimulation (VNS) devices, neurostimulators, or implanted infusion pumps. 7. Participants with metallic implants in the head or neck region that, in the opinion of the Investigator, may interfere with the safe use of the investigational device. 8. Participants who are physically incapacitated such as to manoeuvre the ZeusOSA device 9. Adults with long facial hair that interferes with the correct placement of the hydrogel pad, and who are unwilling to shave. 10. Participants with an allergy to plasters or similar products.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The study's own enquiry address
This study publishes an address for enquiries. See it below .
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does concentrating change your breathing? study probes Brain-Breath link in opioid users
- Can software read sleep studies as well as a specialist?
- Monthly shot aims to quiet sleep apnea and shed pounds
- Can light therapy shrink tonsils and ease Kids' sleep apnea?
- Breathing brief Low-Oxygen bursts may boost sleep apnea treatment
- Can adding ketamine to propofol improve sleep apnea scans?